Výsledky vyhľadávania
- Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer / Ray-Coquard I., Minárik T. ... [et al.] . Onkológia. - ISSN 1336-8176 . - Roč. 14, č. 5 (2019), s. 372
- C 3069